fivefold more bound virus than HeLa cells. Thus, the binding of EMC virus to murine cells is reversible at the increased temperature. After exa.mining several lymphoid cell populations, Dr. McClintock and his colleagues found that bone marrow cells and macrophages have EMC virus receptors, but spleen cells and thymocytes do not. The number of EMC receptors present on the former cell types can be altered in several ways, as exemplified by the fact that thioglycolatestimulated macrophages bind twice as much EMC virus as resident peritoneal macrophages, and that mitogens such as PHA, LPS, and Con A induce an increased amount of receptors on lymphoid cells. In addition, the number of EMC receptors fluctuates depending on the cell growth cycle. The C3 complement receptor and activation of complement was discussed by Peter Lachmann (Cambridge) . Once an antibody response is mounted against viral determinants expressed on the cells' plasma membranes, the complement cascade can be activated. In addition, certain viral glycoproteins, by themselues, may activate the alternative complement pathway in the absence of antibody. Under these conditions, C3 can bind nonspecifically to acceptors on the plasma membrane and this type of binding by C3 differs from the binding of C3 to specific receptors (C3b, C3bi, C3d). Cells that potentially express such receptors are monocytes, granulocytes, lymphocytes, and lymphoblastoid cell lines, but they vary in the number as well as type of C3 receptors present on their plasma membranes. The various receptors are difficult to isolate because of their sensitivity to proteases, reducing agents, heat, phospholipase, organic solvents, detergents, and freeze thawings. Nevertheless, the C3b receptor has been isolated recently and1 the molecular weight is approximately 200,000. This molecule is similar to @lH, an inhibitor of C3b, although the binding site is physically different. The C3b receptor on phagocytic cells is thought to function in the adherence of complement-coated bacteria to cells and in signaling for endocytosis. Binding to the receptor can activate macrophages and may induce the secretion of other complement components. Little is known about the function of these receptors on lymphocytes, although binding to these cells may trigger the induction of enzymes. Interestingly enough, the C3d receptor on B cells is closely associated with the receptor for Epstein-Barr virus.
The ability of interferon to regulate the immune response was examined by E. De Maeyer (Paris). Recently, mouse interferon has been purified to two electrophoretically pure glycoproteins with molecular weights of 35,000 and 22,000. With purified interferon, it was possible to demonstrate the biological properties of interferon including inhibition of cell growth, antibody formation in vitro, tumor growth and delayed type hypersensitivity in vitro, tumor growth induction, and H-2 antigenic expression on cells. However, this purified preparation does not inhibit the synthesis of new interferon even at high concentrations which was one of the notable properties of unpurified interferon preparations. The effect of host genotype on the induction of interferon was examined by using Newcastle disease virus (NDV). NDV induces 10 times more circulating interferon in C57BLi6 mice than in BALB/c mice. The cause is a single Mendelian locus called If-1, which is not linked to the H-2 complex. After examination of recombinant C57BU6 and BALB/c mice, the If-l locus was linked to the H-28 marker on murine chromo-some number 3. The If-l locus is specific for the interferon response to NDV. because there was no difference in the amount of interferon induced in recombinant inbred mice after exposure to other interferon inducers. The If-l locus is also associated with the delayed type hypersensitivity response (footpad swelling) to NDV. Other loci in the C57BW6 background are also involved since a recombinant inbred strain which is mostly BALB/c but contains the H-28 marker from C57BW6 strain does not exhibit footpad swelling after NDV challenge. The discussion turned to suppressor T cells in health and disease. M. Oldstone (La Jolla) presented data from his laboratory (L. Olding, J. Huddlestone, A. Tishon) that T suppressor cells are activated in ~,ir>o (>859%) in human fetuses prior to delivery and in patients with multiple sclerosis during the remission state following an acute attack. Such activated T suppressor cells are not found in the health population (<IO%). Cells within this population are marked by E rosetting, bear Fc receptors for IgG, and specifically bind monoclonal antibodies OKT5 or OKT8 and OKMl.
The possibility that OKMl recognized the Fc receptor of IgG on macrophages as well as T cells and the indication that T cells bearing Fc receptors bore monoclonal T-cell markers was mentioned. Activated suppressor cells in human fetuses occurred as early as 8 weeks postgestation and lasted I to I ti years after birth according to data generated by Lars Olding and colleagues (Gothenberg). Activated suppressor cells in patients with multiple sclerosis were restricted to the time of remission following an acute attack, and were absent during chronic, slowly progressive, or stable multiple sclerosis.
The next theme concerned the regulation of virus replication and persistence. Harold Ginsberg (New York) discussed proteins as regulators using adenovirus replication as an example. Ginsberg and colleagues have characterized the adenovirus genome and examined five regions of early transcription.
Each region is noncontiguous yet cooperatively controlled. For example. region IA must be expressed early before the remaining early regions can be transcribed. A temperature sensitive mutant (ts125) continues to transcribe region 4 at the nonpermissive temperature for the parent virus. indicating the probability of a lesion in the repressor protein. This ts125 virus is also interesting because it transforms cells at a 5-to IO-fold higher frequency than wild-type adenovirus. The pattern of viral DNA integration differs as well in the two types of virus in that all of the ts125 genome. but only 15% of the wild-type genome. is integrated in transformed cells. One cell line transformed by ts125 has been examined for its content of viral mRNA. These cells make all virus mRNAs except the one that codes the virion fiber (involved in attachment of virions to cells) and, thus. do not produce infectious virus. Why this cell line does not make the mRNA for fiber is not known. However. monkey kidney cells infected with adenovirus also make all viral mRNAs except the mRNA for fiber. Cellular activities may also be regulated through the phosphorylation of proteins. Kinases. as described by Alice Huang (Boston), increase the phosphorylation of proteins and generally inactivate systems. whereas phosphatases decrease phosphorylation and commonly activate cellular events. Phosphorylation alters the charge and may change the configuration of phosphoproteins.
Several kinases not involved with viruses include one that causes synthesis of a controlling protein for heme. an interferon-induced kinase, and a kinase tyrosine that is activated by EGF (cell growth control protein) binding to its cell receptors. Several kinases of animal viruses are ATP independent. Dr. Huang used as an example of these concepts the kinase associated with vesicular stomatitis virus (VSV). This can phosphorylate in Vito some of the structural proteins in the virion. The amino acids which are phosphorylated are serine, threonine, and tyrosine. John Holland (San Diego) introduced the area of mutant viruses as regulators by addressing the long-term interaction of VSV with cells, VSV is a cytolytic virus and kills the cells that it infects. To establish a persistent VSV infection in ,~itro, cells must be infected simultaneously with the standard virus and a subgenomic deletion mutant called defective interfering (DI) virus that has the ability to inhibit the replication of the standard form. Long-term cultures of these persistently infected cells have remained viable for over 7 years. This allows the virion nucleic acid to enter the cell after which viral replication proceeds. Cleavage of the F protein is essential for viral infectivity and cytopathic effects. Permissiveness for infectivity by a particular virus in 11itvo correlates with a cell's ability to cleave that virus' F protein. That is, for multiple cycles of replication to occur the infected cell must produce functional F Iprotein. In addition, a virus' virulence i,r \li\~ also correlates with the cleavage of its F protein. The cell's specific cleaving enzyme has trypsin-like activity, as shown by the use of mutant viruses. Cleavage of the F protein results in conformational changes in the molecule during which the hydrophobic ends become exposed. The cleavage site is highly conserved within the paramyxovirus group. Sequencing the terminal ends has shown that the same specific amino acids are present and synthetic peptides which mimic the terminal ends can inhibit fusion. The last series of discussions concerned the pathogenesis of diseases induced by viruses and/or immune responses. A. L. Notkins (Bethesda) started the section on virus-induced diseases by speaking about diabetes induced in mice by encephalomyocarditis virus (EMC). Two variants isolated by selecting separate plaques differed in their abilities to induce diabetes. One variant (called D virus) caused diabetes in 95 to 100% of the mice tested, whereas the second or B variant was not diabetogenic. There were several significant differences between the D and B variants. For example, the Islets of Langerhans from the pancreases of mice infected with the D variant virus contained more viral antigens measured by immunofluorescence and IO-to 100-fold more infectious virus than those from mice infected with the B variant virus. In addition. the B variant induced more interferon both in isitro and in lvi\w than the D variant. which may explain why the B variant produces a self-limiting infection that does not cause diabetes in mice. When the RNA genomes of the B and D variant viruses were compared by RNase T, fingerprinting, only one oligonucleotide difference was observed. The genetic background of the host is significant in the induction of diabetes by the D variant in that some mouse strains are susceptible and others are resistant. The Islets of Langerhans in resistant mouse strains infected with the D variant virus contain only a low level of viral antigen, indicating that not enough cells are killed by the virus to produce diabetes. The effect of the drug streptozotocin, which is toxic for /? cells and can produce diabetes, was also examined. When a subdiabetogenic dose of streptozotocin is combined with a small amount of the D variant virus, the effect is cummulative and diabetes is produced. In fact, streptozotocin can induce diabetes in resistant mouse strains if given with the D variant virus, or in mice susceptible to the D variant infected with the nondiabetogenic B variant virus. The diabetogenic potential of other viruses such as Coxsackie B3 or B5 was also observed by combining them with streptozotocin.
These results show that the induction of diabetes by viruses in mice depends on: (1) the genetics of the virus: (2) the genetic background of the mouse; (3) the /3 cell "reserve" of the animal: and (4) the cumulative effect of several agents on the p cells. Notkins also provided data that antibodies to p cells are generated during these virus infections and suggested that such autoimmune antibodies may play a role .in the disease. Catherine Fabricant (Ithaca) presented a model for virus-induced atherosclerosis in pathogen-free chickens experimentally infected with Marek's disease virus (MDV: a herpesvirus). Whether or not the animals' diet contained cholesterol, atherosclerotic coronary and gut arterial lesions are observed several months after infection. At this time, some arteries are almost completely blocked by the proliferation of "foam" cells (smooth muscle cells containing large quantities of lipids). The first microscopic evidence of arterial lesions appears as early as one month after MDV infection of animals given a diet containing 0.025% (w/w) cholesterol. But, when these animals are shifted to a high cholesterol (2%, w/w) diet, a synergistic effect is observed. Dr. Fabricant found evidence of viral antigens in aortic segments of the animals' arterial lesions by using immunofluorescence.
Moreover, MDV-infected smooth muscle cell cultures showed an increase in the content of lipids compared to uninfected cells or cells infected with HVT (herpesvirus of turkeys-the vaccine used against MDV). Three possible mechanisms of MDVinduced atherosclerosis were presented: (1) an arterial injury due to virus infection; (2) an immunologic response to virus-infected arterial cells; and (3) an alteration of lipid metabolism in virus-infected smooth muscle cells,. Whatever the mechanism, MDV infection of chickens fed a diet with normal cholesterol levels results in a type of atherosclerosis that closely resembles chronic human arterial disease. Michael Oldstone discussed two models of virus-induced demyelination in mice. In the first model, wild mouse virus (a retrovirus) infects and kills motor neurons as well as oligodendrocytes.
The host's genetic background determines whether it will develop the disease. Genetic susceptibility to the wild mouse virus-induced disease indicates that two recessive genes are involved and correlates with the FV-1, gene but is not H-2 linked. Comparison of the ecotropic and amphotropic wild mouse retroviruses that have the same p30 protein but different gp7Os (glycoproteins) show that the ecotropic virus causes this disease. The gp70 appears important in determining whether or not the virus initially binds to the neuron or oligodendrocyte.
However, the FV-1, gene, which is known to act at the level of p30 synthesis, also exerts control over virus replication. Two other wild mouse viruses (18112 and 4966), which have the same gp7Os but different p30 proteins than the ecotropic virus, do not cause either production of p30 protein nor disease in mice. The second model of demyelination is induced by mouse hepatitis virus (MHV) type 4 (a coronavirus).
Wild-type MHV causes encephalitis. but rarely demyelination, in mice. However, temperature sensitive mutants have been isolated that do not cause encephalitis, but do induce a high rate of demyelination.
This demyelination results from dysfunction induced by MHV infection of oligodendrocytes, which are the cells that produce and maintain myelin around the nerve axons. Both the oligodendrocyte and the myelin sheaths around the axons contain viral antigens. A single autosomal gene, dominant but not H-2 linked, is associated with disease. Interest in the models of MHV, endomyocarditis virus, and reovirus was in the possibility that these virus shared receptors with both target tissues. i.e., oiigodendrocytes and neurons as well as lymphocytes. Recent advances in culturing purified populations of oligodendrocytes (presented by J. DeVellis, Los Angeles) and neurons allow these studies to be undertaken.
